LAURA THIBODAUX: Open Payments
NPI 1285207860 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 21 payments from 8 companies in 2025. Trend: 2023 $420 · 2024 $479 · 2025 $528
Food & beverage: $464Education: $64
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $213 |
| Actelion Pharmaceuticals US, Inc. | 4 | $153 |
| PFIZER INC. | 2 | $41 |
| Amgen Inc. | 1 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Liquidia Technologies, Inc. | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VERQUVO, OPSUMIT, ELIQUIS, REPATHA, OPSYNVI, LEQVIO, CAPVAXIVE, WINREVAIR.
Industry payments across TX — which companies pay providers there.
